Mutations in the ferroportin gene (SLC40A1) can lead to disorders such as hemochromatosis, where iron accumulates in tissues, leading to toxicity. Conversely, low levels of ferroportin activity can result in iron deficiency anemia, characterized by insufficient iron supply to meet the body's needs.